Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. Its pipeline is focused on creating antibody-drug conjugate and immune-oncology conjugate candidates. The company develops the treatment of breast cancer, gastric/gastroesophageal junction (GEJ) cancer, and other solid tumors.
|HQ||San Diego, CA, US||Map|
Market capitalization (18-Oct-2021)
Closing stock price (18-Oct-2021)
When was Ambrx founded?
Ambrx was founded in 2003.
Who are Ambrx key executives?
Ambrx's key executives are Feng Tian, Joy Yan and Shawn Zhang.
How many employees does Ambrx have?
Ambrx has 70 employees.
Who are Ambrx competitors?
Competitors of Ambrx include Pharming Group, Ocugen and Graphite Bio.
Where is Ambrx headquarters?
Ambrx headquarters is located at 10975 N Torrey Pines Rd, La Jolla, San Diego.
Where are Ambrx offices?
Ambrx has an office in San Diego.
How many offices does Ambrx have?
Ambrx has 1 office.
Receive alerts for 300+ data fields across thousands of companies